This condition favours lipid peroxidation, DNA fragmentation, and eventual cellular necrosis [3]
Developed by Eli Lilly, retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors a mechanism that sets it apart from currently approved medicines such as semaglutide and tirzepatide
While GLP-1s have undergone extensive human trials and are licensed by the MHRA, the UK's medicines watchdog, there is a "grey market" of other peptides emerging
What to know Most side effects appear early in treatment and usually improve as your body adjusts to the dose
Contact your healthcare provider promptly if you experience severe vomiting, diarrhoea, or signs of dehydration
This is collagen that has been broken down into smaller, shorter chains of amino acids